Max Healthcare Institute Ltd

Max Healthcare Institute's stock has declined for two consecutive days, resulting in an overall decrease of 8.74%. The stock's intraday performance showed a low of Rs 1,037.05. Over the past month, it has underperformed compared to the broader market, reflecting ongoing challenges in the healthcare sector.

Max Healthcare Institute's stock has declined for two consecutive days, resulting in an overall decrease of 8.74%. The stock's intraday performance showed a low of Rs 1,037.05. Over the past month, it has underperformed compared to the broader market, reflecting ongoing challenges in the healthcare sector.

Max Healthcare Institute's stock has declined for two consecutive days, resulting in an overall decrease of 8.74%. The stock's intraday performance showed a low of Rs 1,037.05. Over the past month, it has underperformed compared to the broader market, reflecting ongoing challenges in the healthcare sector.

Max Healthcare Institute faced a challenging trading day on February 10, 2025, with a notable decline in stock performance. The company underperformed compared to the sector, and while it shows longer-term stability above certain moving averages, it is experiencing short-term volatility and a decline over the past month.

Max Healthcare Institute has faced a decline on February 6, 2025, marking its second consecutive day of losses. The stock has underperformed compared to the broader market over the past month, although it remains above several key moving averages, suggesting a longer-term positive trend in its price movement.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.

Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.